IBIO
iBio, Inc.NASDAQHealthcare$1.98+2.53%ClosedMarket Cap: $31.3M
As of 2026-04-06
Analyst Consensus
Consensus
Buy
Target (Consensus)
$2.00
Target (Median)
$2.00
Target Range
$2.00 - $2.00
Upside from current price: 1.0%
Rating Distribution
0 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-18 | Chardan Capital | maintain | Buy | Buy |
| 2026-02-12 | Chardan Capital | maintain | Buy | Buy |
| 2025-06-25 | Chardan Capital | maintain | Buy | Buy |
| 2025-05-06 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Wed Jun 30 | $-0.29 | $120.0K | 3 |
| Fri Jun 30 | $-0.35 | $250.0K | 1 |
| Sat Jun 30 | $-0.47 | $500.0K | 1 |
| Sun Jun 30 | $-0.46 | $500.0K | 1 |